U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C29H39NO2
Molecular Weight 433.6255
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of MOFAROTENE

SMILES

C\C(=C/C1=CC=C(OCCN2CCOCC2)C=C1)C3=CC4=C(C=C3)C(C)(C)CCC4(C)C

InChI

InChIKey=OUQPTBCOEKUHBH-LSDHQDQOSA-N
InChI=1S/C29H39NO2/c1-22(24-8-11-26-27(21-24)29(4,5)13-12-28(26,2)3)20-23-6-9-25(10-7-23)32-19-16-30-14-17-31-18-15-30/h6-11,20-21H,12-19H2,1-5H3/b22-20+

HIDE SMILES / InChI

Molecular Formula C29H39NO2
Molecular Weight 433.6255
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Mofarotene is an analog of retinoic acid patented by a Swiss multinational healthcare company Hoffmann-La Roche as neoplasm inhibitors and agent for treating dermatoses. Like other retinoic acid agents, mofarotene binds to and activates retinoic acid receptors (RARs), thereby altering the expression of certain genes leading to cell differentiation and decreased cell proliferation in susceptible cells. Mofarotene has demonstrated considerable antitumor activity in a number of cancer cell lines. Mofarotene in combination with cisplatin and etoposide was studied in phase I clinical trials but further development was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer.
1999 Apr
Patents

Sample Use Guides

The doses of Ro 40-8757 ranged from 84 mg/m2 once daily to 42 mg/m2 thrice daily (tid).
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:31:24 GMT 2023
Edited
by admin
on Fri Dec 15 15:31:24 GMT 2023
Record UNII
8K3CVY8F8V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MOFAROTENE
INN   MI  
INN  
Official Name English
4-(2-(4-((E)-2-(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHYL)PROPENYL)PHENYLOXY)ETHYL)MORPHOLINE
Systematic Name English
mofarotene [INN]
Common Name English
MOFAROTENE [MI]
Common Name English
RO 40-8757
Code English
Classification Tree Code System Code
NCI_THESAURUS C804
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C63667
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
MERCK INDEX
m7586
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY Merck Index
CAS
125533-88-2
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
SMS_ID
100000080332
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
PUBCHEM
5467732
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
EPA CompTox
DTXSID7032006
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
FDA UNII
8K3CVY8F8V
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
INN
7114
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
ChEMBL
CHEMBL146506
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
EVMPD
SUB09032MIG
Created by admin on Fri Dec 15 15:31:24 GMT 2023 , Edited by admin on Fri Dec 15 15:31:24 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY